| CAT No: | CL-MPVR-32 |
| CAS No: | 886538-46-1 |
| Mol.F: | C13H19N3O6 |
| Mol.Wt.: | 313.3 |
| Chemical Name: | ((2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl isobutyrate |
| Inventory Status: | Custom synthesis |
This impurity is related to Molnupiravir Impurity 13 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Molnupiravir Impurity 13 is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:((2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl isobutyrateCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Molnupiravir Molecular Formula: C13H19N3O6
Molecular Weight: 313.3
Storage: Store in a cool, dry place.
| Product Name: | Molnupiravir Impurity 13 |
| CAS No: | 886538-46-1 |
| Mol.F.: | C13H19N3O6 |
| Mol.Wt.: | 313.3 |
Cat. No: CL-MPVR-01
CAS No: 2492423-29-5
Mol. F: C13H19N3O7
Mol. Wt: 329.3
Inv. Status: Custom Synthesis
Cat. No: CL-MPVR-02
CAS No: 2346620-55-9
Mol. F: C16H23N3O7
Mol. Wt: 369.4
Inv. Status: In Stock
Cat. No: CL-MPVR-03
CAS No: 886538-48-3
Mol. F: C13H18N2O7
Mol. Wt: 314.3
Inv. Status: Custom Synthesis
Cat. No: CL-MPVR-06
CAS No: NA
Mol. F: C11H15N3O7
Mol. Wt: 301.3
Inv. Status: Custom Synthesis
Cat. No: CL-MPVR-08
CAS No: NA
Mol. F: C13H19N3O7
Mol. Wt: 329.3
Inv. Status: Custom Synthesis
Cat. No: CL-MPVR-09
CAS No: NA
Mol. F: C13H19N3O7
Mol. Wt: 329.3
Inv. Status: Custom Synthesis
Cat. No: CL-MPVR-10
CAS No: 2684302-84-7
Mol. F: C17H25N3O8
Mol. Wt: 399.4
Inv. Status: Custom Synthesis
Cat. No: CL-MPVR-13
CAS No: 362-43-6
Mol. F: C12H16N2O6
Mol. Wt: 284.3
Inv. Status: Custom Synthesis
Cat. No: CL-MPVR-14
CAS No: 2346620-54-8
Mol. F: C18H23N5O6
Mol. Wt: 405.4
Inv. Status: Custom Synthesis
Cat. No: CL-MPVR-17
CAS No: 2/8/3258
Mol. F: C9H13N3O6
Mol. Wt: 259.22
Inv. Status: In Stock
Cat. No: CL-MPVR-18
CAS No: 1955522-00-5
Mol. F: C12H17N3O5 : H2O4S
Mol. Wt: 283.3 : 98.1
Inv. Status: In Stock
Cat. No: CL-MPVR-20
CAS No: NA
Mol. F: C13H18N2O7
Mol. Wt: 314.29
Inv. Status: In Stock
Cat. No: CL-MPVR-15
CAS No: 362-42-5
Mol. F: C12H17N3O5
Mol. Wt: 283.3
Inv. Status: Custom Synthesis
Cat. No: CL-MPVR-16
CAS No: 1955522-00-5
Mol. F: C12H17N3O5 H2O4S
Mol. Wt: 283.3 98.1
Inv. Status: Custom Synthesis
Cat. No: CL-MPVR-30
CAS No: 1686124-74-2
Mol. F: C16H23N3O6
Mol. Wt: 353.4
Inv. Status: Custom Synthesis
Cat. No: CL-MPVR-31
CAS No: 2346620-55-9
Mol. F: C16H23N3O7
Mol. Wt: 369.4
Inv. Status: Custom Synthesis
Cat. No: CL-MPVR-19
CAS No: NA
Mol. F: C9H13N3O5
Mol. Wt: 243.2
Inv. Status: Custom Synthesis
Cat. No: CL-MPVR-21
CAS No: NA
Mol. F: C16H26N4O8
Mol. Wt: 402.4
Inv. Status: Custom Synthesis
Cat. No: CL-MPVR-22
CAS No: 2346619-88-1
Mol. F: C21H31N3O9
Mol. Wt: 469.5
Inv. Status: Custom Synthesis
Cat. No: CL-MPVR-23
CAS No: NA
Mol. F: C16H26N4O7
Mol. Wt: 386.4
Inv. Status: Custom Synthesis
Cat. No: CL-MPVR-24
CAS No: NA
Mol. F: C16H23N3O7
Mol. Wt: 369.4
Inv. Status: Custom Synthesis
Cat. No: CL-MPVR-25
CAS No: NA
Mol. F: C16H23N3O6
Mol. Wt: 353.4
Inv. Status: Custom Synthesis
Cat. No: CL-MPVR-26
CAS No: 13491-41-3
Mol. F: C9H13N3O6
Mol. Wt: 259.2
Inv. Status: Custom Synthesis
Cat. No: CL-MPVR-27
CAS No: NA
Mol. F: C9H13N3O5
Mol. Wt: 243.2
Inv. Status: Custom Synthesis
-Hydroxycytidine.jpg)
Cat. No: CL-MPVR-28
CAS No: 4/2/3258
Mol. F: C9H13N3O6
Mol. Wt: 259.2
Inv. Status: Custom Synthesis
Cat. No: CL-MPVR-29
CAS No: 2770244-32-9
Mol. F: C13H19N3O7
Mol. Wt: 329.3
Inv. Status: Custom Synthesis
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: